Weakly Supervised LSTM RNNs for Longitudinal Breast Cancer Recurrence Prediction via Unstructured Clinical Narratives
ISEF · 2020 Robotics and Intelligent Machines
Overview
Breast cancer is the most common cancer in women globally, causing an estimated 626,700 deaths in 2018. As the late detection of breast cancer recurrence leads to a 1-1.5% curability rate, my project presents the first attempt to predict breast cancer recurrence, 1 year in advance, by leveraging unstructured clinical narratives in EHR over a patient’s temporal visit sequence. I first develop robust, encoded representations of the unstructured clinical narratives. This is done through text preprocessing in which notes are standardized, noise is eliminated, and semantic meaning is preserved. Next, I train unsupervised word2vec embeddings across a corpus of ~100 million notes from 3 institutions for increased generalization. Finally, robust document-level embeddings are computed as a weighted average of word vectors in the document. Using the document-level embeddings, I train a weakly supervised, many-to-many, stacked stateful LSTM RNN for longitudinal recurrence prediction. The model is validated, trained, and tested on ~154K notes from 940 distinct patients, achieving 0.841 ROC AUC on the hold-out test set. The model’s comprehensive, fully automated analysis of unstructured clinical narratives with limited ground truth labels can also be generalized to other types of cancers and diseases to offer key insights into future clinical events. Unlike previous “black-box” models, my model can be visualized, engendering trust in clinicians to leverage and utilize its personalized predictions as a pivotal part in determining adequate treatment. This allows clinicians to improve patient survival by treating recurrences earlier and even preventing them from occurring in the first place.
Competition history
- ISEF 2020
Resources
Related projects
ISEF · 2025
OncoNote: Enabling the Discovery of a Novel Digital Biomarker for Early Pan-Cancer Survival and Recurrence Prediction via Free-Text Clinical Narratives
ISEF · 2018
Deep, Multimodal Representation Learning for Pan-Cancer Prognosis Prediction
ISEF · 2023
A Novel Breast Cancer Recurrence Risk Predictor Using a Deep Learning Multi-omics Data Integration Framework
ISEF · 2026
OncoTwin: A Multi-Modal, Treatment-Based Digital Twin for Cancer Recurrence Risk Prediction and Biomarker Discovery
ISEF · 2023
BioRx: An Integrative NLP Approach to Early Survival and Recurrence Prediction and Novel Biomarker Discovery in Unstructured Text-Based Clinical Narratives for Diabetes Patients
ISEF · 2025
RecuNet: A Novel, Low-Cost, & Automated Pipeline for the Spatiotemporal Prediction of Brain Tumor Recurrence
ISEF · 2024
Predictive Modeling of Brain Tumor Evolution and Anatomical Invasion: A Novel 3D Time Series Forecasting Approach for Enhanced Treatment Planning
ISEF · 2024
Accelerating Breast Cancer Diagnoses: Leveraging Machine Learning to Accurately Predict Breast Cancer Presence and Growth With Hormonal Data
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair